Worldwide genome editing market size to exhibit 22.9% CAGR through 2027

The ‘Global Genome Editing Market’ provides a broad perspective of the major development trends, challenges & restraints, and other revenue-generating opportunities prevailing in this industry vertical.


Selbyville, Delaware, July 08, 2021 (GLOBE NEWSWIRE) -- Global genome editing market, as per seasoned analysts, had reached a valuation of USD 3.7 billion in the year 2020 and is likely to record a 22.9% compound annual growth rate during the study period, eventually accounting for USD 15.67 billion by 2027.

The study also scrutinizes this business domain through its segmentations, specifically the application scope and the end-user spectrum. Statistical information such as market share and growth rate predictions of each segment is included in the study. Additionally, the report provides significant information regarding the geographical reach of this business space and concludes with a detailed SWOT analysis of the market majors.

It is worth noting that genome editing allows scientists to make some changes to the DNA, further resulting in changes to the physical traits including disease risk or eye color. Thus, growing demand for synthetic genes coupled with increasing popularity of CRISPR genome editing technologies are the primary growth stimulants of global genome editing market.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/3959171/

Increasing R&D activities and subsequent innovative product launches are also facilitating the business scenario. However, complexities associated with clinical translation could potentially act as a restraining factor to the growth of global genome editing industry.

Summarizing the market segmentations

The report bifurcates global genome editing industry on the basis of its application reach and end-user scope. Speaking of the application spectrum, the market is further divided into clinical applications and genetic engineering.

The end-user scope of this business space includes contract research organizations, academic & government research institutes, and biotechnology & pharmaceutical companies.

From the geographical point of view

Global genome editing market, based on regional analysis, has been segmented into North America, Europe, Asia-Pacific, Latin America, and the rest of the world.

Among these, experts cite that North America is likely to emerge as a major revenue contributor for the industry participants by 2027. Factors including technological breakthroughs in gene editing solutions coupled with surging investments in biotechnology sector are facilitating the regional business outlook.

On the other hand, Asia-Pacific genome editing industry share is expected to record substantial growth in the ensuing years, primarily driven by improving healthcare infrastructure, growing population, and rapid developments in biotechnology space.

To access a sample copy or view this report in detail along with the table of contents, please click the link below:

https://www.marketstudyreport.com/reports/global-genome-editing-market-size-research

Global Genome Editing Market Application Spectrum (Revenue, USD Billion, 2018-2027)

  • Clinical Applications
  • Genetic Engineering

Global Genome Editing Market End-user Analysis (Revenue, USD Billion, 2018-2027)

  • Contract Research Organization (CROs)
  • Academic & Government Research Institutes
  • Biotechnology & Pharmaceutical Companies

Global Genome Editing Market Geographical Contribution (Revenue, USD Billion, 2018-2027)

North America

  • Canada
  • United States

Asia-Pacific

  • South Korea
  • Japan
  • India
  • Australia
  • China
  • Rest of Asia-Pacific

Europe

  • Italy
  • Spain
  • United Kingdom
  • Germany
  • France
  • Rest of Europe

Latin America

  • Brazil
  • Mexico

Rest of the World

Global Genome Editing Market Competitive Terrain (Revenue, USD Billion, 2018-2027)

  • Cellectis
  • Caribou Biosciences Inc.
  • Intellia Therapeutics Inc.
  • CRISPR Therapeutics AG
  • Editas Medicine
  • Sangamo Therapeutics Inc.
  • Recombinetics Inc.
  • Cibus Ltd.
  • The Merck Group
  • Precision Biosciences Inc.

Table of Content:

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Genome editing Market, by region, 2019-2027 (USD Billion)

1.2.2. Genome editing Market, by Application, 2019-2027 (USD Billion)

1.2.3. Genome editing Market, by End use, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Genome editing Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Genome editing Market Dynamics

3.1. Genome editing Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Success in pre-clinical models drives demands for genome editing therapeutics

3.1.1.2. Rising adoption in biotechnology

3.1.2. Market Challenges

3.1.2.1. Challenges with respect to clinical translation

3.1.3. Market Opportunities

3.1.3.1. Technological advancements in gene editing technologies

Chapter 4. Global Genome editing Market Industry Analysis

4.1. Porter's 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Genome editing Market, by Application

5.1. Market Snapshot

5.2. Global Genome editing Market by Application, Performance - Potential Analysis

5.3. Global Genome editing Market Estimates & Forecasts by Application 2018-2027 (USD Billion)

5.4. Genome editing Market, Sub Segment Analysis

5.4.1.  Genetic Engineering

5.4.2. Clinical Applications

Chapter 6. Global Genome editing Market, by End use         

6.1. Market Snapshot

6.2. Global Genome editing Market by End use, Performance - Potential Analysis

6.3. Global Genome editing Market Estimates & Forecasts by End use 2018-2027 (USD Billion)

6.4. Genome editing Market, Sub Segment Analysis

6.4.1.  Biotechnology & Pharmaceutical Companies

6.4.2. Academic & Government Research Institutes

6.4.3. Contract Research Organizations (CROs)

Chapter 7. Global Genome editing Market, Regional Analysis

Related Report:

Gene Editing Market Size, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026

Global Gene editing market is likely to record substantial growth in coming years owing to rising incidences of genetic disorders, ongoing development of advanced gene editing technologies, and high adoption of CRISPR technology. Gene editing or genome editing is group of technologies that gives scientist the capability to change DNA of an organism, including animals, bacteria, and plants. Editing DNA could further lead to changes in physical traits such as disease risk, and eye color. Scientist generally utilize different technologies to do this. These technologies, further allow the genetic material to be altered, removed or added at a specific place in the genome.

From a regional frame of reference, Latin America gene editing market will witness substantial growth over the coming years. The region in 2019, accounted for over 11% market share, attributable to rising incidences of genetic disorders across several Latin American countries.

North America Genetic Testing Market, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026

Growing incidences of genetic disorders and cancer will serve to be a key factor for North America genetic testing market growth over the upcoming years. Moreover, technological advancement has been a boon in the industry for early detection and treatment of diseases and disorders. According to the National Institutes of Health (NIH), one in 15,000 children suffer from phenylketonuria every year. The early detection of genetic disorders is helpful and essential for further treatment and hence, the increase in genetic testing demand will upsurge the genetic testing market growth in the forecast period.A North America Genetic Testing Market ShareA Estimated To Exceed USD 15.0 Billion By 2026.A

About US:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

 

Contact Data